259 related articles for article (PubMed ID: 19919989)
1. Adaptive and maladptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading.
Divakaran V; Adrogue J; Ishiyama M; Entman ML; Haudek S; Sivasubramanian N; Mann DL
Circ Heart Fail; 2009 Nov; 2(6):633-42. PubMed ID: 19919989
[TBL] [Abstract][Full Text] [Related]
2. Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice.
Biernacka A; Cavalera M; Wang J; Russo I; Shinde A; Kong P; Gonzalez-Quesada C; Rai V; Dobaczewski M; Lee DW; Wang XF; Frangogiannis NG
Circ Heart Fail; 2015 Jul; 8(4):788-98. PubMed ID: 25985794
[TBL] [Abstract][Full Text] [Related]
3. N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin.
Liu YH; D'Ambrosio M; Liao TD; Peng H; Rhaleb NE; Sharma U; André S; Gabius HJ; Carretero OA
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H404-12. PubMed ID: 19098114
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-21 is involved in direct actions of ursolic acid on the heart: implications for cardiac fibrosis and hypertrophy.
Dong X; Liu S; Zhang L; Yu S; Huo L; Qile M; Liu L; Yang B; Yu J
Cardiovasc Ther; 2015 Aug; 33(4):161-7. PubMed ID: 25903305
[TBL] [Abstract][Full Text] [Related]
5. The Smad3-miR-29b/miR-29c axis mediates the protective effect of macrophage migration inhibitory factor against cardiac fibrosis.
Liang JN; Zou X; Fang XH; Xu JD; Xiao Z; Zhu JN; Li H; Yang J; Zeng N; Yuan SJ; Pan R; Fu YH; Zhang M; Luo JF; Wang S; Shan ZX
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2441-2450. PubMed ID: 31175931
[TBL] [Abstract][Full Text] [Related]
6. MiR-195 inhibits myocardial fibrosis in hypertensive rats by regulating TGFβ1-Smad3 signaling pathway.
Xu Q; Lin XX; Liu P; Zhang W; Tang K; Zhai YS; Liu LJ; Mei WY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8087-8094. PubMed ID: 31599435
[TBL] [Abstract][Full Text] [Related]
7. The microRNA-15 family inhibits the TGFβ-pathway in the heart.
Tijsen AJ; van der Made I; van den Hoogenhof MM; Wijnen WJ; van Deel ED; de Groot NE; Alekseev S; Fluiter K; Schroen B; Goumans MJ; van der Velden J; Duncker DJ; Pinto YM; Creemers EE
Cardiovasc Res; 2014 Oct; 104(1):61-71. PubMed ID: 25103110
[TBL] [Abstract][Full Text] [Related]
8. Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling.
Bujak M; Ren G; Kweon HJ; Dobaczewski M; Reddy A; Taffet G; Wang XF; Frangogiannis NG
Circulation; 2007 Nov; 116(19):2127-38. PubMed ID: 17967775
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor.
Sakata Y; Chancey AL; Divakaran VG; Sekiguchi K; Sivasubramanian N; Mann DL
Basic Res Cardiol; 2008 Jan; 103(1):60-8. PubMed ID: 18034274
[TBL] [Abstract][Full Text] [Related]
10. Bone Morphogenetic Protein 9 Reduces Cardiac Fibrosis and Improves Cardiac Function in Heart Failure.
Morine KJ; Qiao X; York S; Natov PS; Paruchuri V; Zhang Y; Aronovitz MJ; Karas RH; Kapur NK
Circulation; 2018 Jul; 138(5):513-526. PubMed ID: 29487140
[TBL] [Abstract][Full Text] [Related]
11. Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity.
Ryu Y; Jin L; Kee HJ; Piao ZH; Cho JY; Kim GR; Choi SY; Lin MQ; Jeong MH
Sci Rep; 2016 Oct; 6():34790. PubMed ID: 27703224
[TBL] [Abstract][Full Text] [Related]
12. microRNA-29b Mediates the Antifibrotic Effect of Tanshinone IIA in Postinfarct Cardiac Remodeling.
Yang F; Li P; Li H; Shi Q; Li S; Zhao L
J Cardiovasc Pharmacol; 2015 May; 65(5):456-64. PubMed ID: 25636075
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-101a suppresses fibrotic programming in isolated cardiac fibroblasts and in vivo fibrosis following trans-aortic constriction.
Zhou Y; Shiok TC; Richards AM; Wang P
J Mol Cell Cardiol; 2018 Aug; 121():266-276. PubMed ID: 30053527
[TBL] [Abstract][Full Text] [Related]
14. Protective Effects of Activated Myofibroblasts in the Pressure-Overloaded Myocardium Are Mediated Through Smad-Dependent Activation of a Matrix-Preserving Program.
Russo I; Cavalera M; Huang S; Su Y; Hanna A; Chen B; Shinde AV; Conway SJ; Graff J; Frangogiannis NG
Circ Res; 2019 Apr; 124(8):1214-1227. PubMed ID: 30686120
[TBL] [Abstract][Full Text] [Related]
15. Growth/differentiation factor 1 alleviates pressure overload-induced cardiac hypertrophy and dysfunction.
Zhang Y; Zhang XF; Gao L; Liu Y; Jiang DS; Chen K; Yang Q; Fan GC; Zhang XD; Huang C
Biochim Biophys Acta; 2014 Feb; 1842(2):232-44. PubMed ID: 24275554
[TBL] [Abstract][Full Text] [Related]
16. Cardiac lineage protein-1 (CLP-1) regulates cardiac remodeling via transcriptional modulation of diverse hypertrophic and fibrotic responses and angiotensin II-transforming growth factor β (TGF-β1) signaling axis.
Mascareno E; Galatioto J; Rozenberg I; Salciccioli L; Kamran H; Lazar JM; Liu F; Pedrazzini T; Siddiqui MA
J Biol Chem; 2012 Apr; 287(16):13084-93. PubMed ID: 22308025
[TBL] [Abstract][Full Text] [Related]
17. Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway.
Xiao H; Ma X; Feng W; Fu Y; Lu Z; Xu M; Shen Q; Zhu Y; Zhang Y
Cardiovasc Res; 2010 Aug; 87(3):504-13. PubMed ID: 20200042
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy.
Koga K; Kenessey A; Ojamaa K
Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H282-93. PubMed ID: 23144312
[TBL] [Abstract][Full Text] [Related]
19. Partial inhibition of activin receptor-like kinase 4 attenuates pressure overload-induced cardiac fibrosis and improves cardiac function.
Li CY; Chen YH; Wang Q; Hou JW; Wang H; Wang YP; Li YG
J Hypertens; 2016 Sep; 34(9):1766-77. PubMed ID: 27379535
[TBL] [Abstract][Full Text] [Related]
20. ADAMTS16 activates latent TGF-β, accentuating fibrosis and dysfunction of the pressure-overloaded heart.
Yao Y; Hu C; Song Q; Li Y; Da X; Yu Y; Li H; Clark IM; Chen Q; Wang QK
Cardiovasc Res; 2020 Apr; 116(5):956-969. PubMed ID: 31297506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
